Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study
Sign Up to like & getrecommendations! Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00745-1
Abstract: Aripiprazole lauroxil (AL) is a long-acting injectable antipsychotic approved for treatment of schizophrenia in adults. Approved AL doses and dosing regimens include 441 mg monthly, 662 mg monthly, and 882 mg monthly or every 6… read more here.
Keywords: week; aripiprazole; safety; study ... See more keywords
In vitro cytogenotoxic evaluation of aripiprazole on human peripheral lymphocytes and computational molecular docking analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Drug and chemical toxicology"
DOI: 10.1080/01480545.2022.2135008
Abstract: Two different drug groups, typical (classic) and atypical (new), are used in the treatment of schizophrenia. Aripiprazole, an atypical antipsychotic chemical, is the active ingredient of the drug Abilify. This study was conducted to determine… read more here.
Keywords: molecular docking; docking analysis; human peripheral; aripiprazole ... See more keywords
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Psychiatry in Clinical Practice"
DOI: 10.1080/13651501.2022.2064308
Abstract: Abstract Objectives Aripiprazole is an antipsychotic with a partial agonism of dopamine D2 and D3 receptors. This differential mechanism implies a rigorous appraisal of the appropriate therapeutic strategies in certain situations. To answer currently unsolved… read more here.
Keywords: aripiprazole treatment; clinical practice; aripiprazole; treatment ... See more keywords
Low-Dose Aripiprazole-Associated Sleepwalking in a Long-Term Zolpidem Treatment Patient With a Depressive Episode: A Case Report.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001001
Abstract: To the Editors: Z olpidem, a member of a family colloquially known as a “Z-drug,” is one of the medications that has been associated with sleepwalking (somnambulism). Aripiprazole is an atypical antipsychotic with dopaminergic partial… read more here.
Keywords: aripiprazole; zolpidem treatment; case; associated sleepwalking ... See more keywords
Aripiprazole-induced transient myopia: A rare entity
Sign Up to like & getrecommendations! Published in 2018 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_907_16
Abstract: Aripiprazole is a new drug for the treatment of adults with schizophrenia. Ocular side effects of aripiprazole are very rare. Review of literature revealed few cases of aripiprazole-induced myopia. We report a rare case of… read more here.
Keywords: induced transient; aripiprazole induced; aripiprazole; transient myopia ... See more keywords